# Chinese expert consensus on the diagnosis and treatment of human immunodeficiency virus infection related diffuse large B cell lymphoma（2025）

PMC · DOI: 10.3760/cma.j.cn121090-20250703-00313 · 2025-09-01

## TL;DR

This paper presents a Chinese expert consensus on diagnosing and treating HIV-related diffuse large B cell lymphoma, aiming to improve clinical practices.

## Contribution

The paper introduces a new expert consensus to standardize diagnosis and treatment of HIV+ DLBCL in China.

## Key findings

- HIV+ DLBCL is rare and challenging to diagnose.
- Current treatment lacks standardization.
- The consensus aims to enhance clinical recognition and management.

## Abstract

人类免疫缺陷病毒感染相关弥漫大B细胞淋巴瘤（human immunodeficiency virus infection related diffuse large B cell lymphoma，HIV+ DLBCL）发病率低，诊断具有挑战性，治疗缺乏规范性。为加强我国临床医师对HIV+ DLBCL的认识，提高诊断及治疗水平，中华医学会血液学分会淋巴细胞疾病学组、中国抗癌协会（CACA）淋巴瘤整合康复专委会、中国临床肿瘤学会（CSCO）淋巴瘤专家委员会中西部免疫缺陷相关淋巴瘤诊治协作组（CALL）组织相关专家，讨论并形成本共识。

## Linked entities

- **Diseases:** diffuse large B cell lymphoma (MONDO:0018905)

## Full-text entities

- **Diseases:** Lymphoma (MESH:D008223), diffuse large B cell lymphoma (MESH:D016403), AIDS Lymphoma (MESH:D016483), Lymphoid Disease (MESH:D008224), Cancer (MESH:D009369), HIV (MESH:D015658)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12580796/full.md

---
Source: https://tomesphere.com/paper/PMC12580796